Premium
Charities and the lure of capitalism
Author(s) -
Wolinsky Howard
Publication year - 2017
Publication title -
embo reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 4.584
H-Index - 184
eISSN - 1469-3178
pISSN - 1469-221X
DOI - 10.15252/embr.201744065
Subject(s) - capitalism , business , biology , political science , law , politics
Many charities employ funding schemes from venture capital to accelerate research and drug development for rare diseases. Though it has yielded new treatments, venture philanthropy prompts raises criticism about the role of charities in marketing and pricing their drugs.